The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Wound Biologics-Global Market Insights and Sales Trends 2024
Synopsis
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The global Wound Biologics market size is expected to reach US$ 5003.5 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Wound Biologics in various end use industries. The expanding demands from the Hospital, Drugstore and Others,, are propelling Wound Biologics market. Biological Skin Substitutes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzyme Preparation segment is estimated at % CAGR for the next seven-year period.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Wound Biologics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Wound Biologics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Wound Biologics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Wound Biologics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Wound Biologics covered in this report include Avita Medical, ConvaTec, Acelity, Cytori Therapeutic, MacroCure, Nuo Therapeutics, Molyncke Health Care, Osiris Therapeutics and Smith And Nephew, etc.
The global Wound Biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Global Wound Biologics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Wound Biologics market, Segment by Type:
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Global Wound Biologics market, by Application
Hospital
Drugstore
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Wound Biologics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Wound Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing. Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
The global Wound Biologics market size is expected to reach US$ 5003.5 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Wound Biologics in various end use industries. The expanding demands from the Hospital, Drugstore and Others,, are propelling Wound Biologics market. Biological Skin Substitutes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzyme Preparation segment is estimated at % CAGR for the next seven-year period.
Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.
In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Wound Biologics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Wound Biologics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Wound Biologics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Wound Biologics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Wound Biologics covered in this report include Avita Medical, ConvaTec, Acelity, Cytori Therapeutic, MacroCure, Nuo Therapeutics, Molyncke Health Care, Osiris Therapeutics and Smith And Nephew, etc.
The global Wound Biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Avita Medical
ConvaTec
Acelity
Cytori Therapeutic
MacroCure
Nuo Therapeutics
Molyncke Health Care
Osiris Therapeutics
Smith And Nephew
Organogenesis
Global Wound Biologics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Wound Biologics market, Segment by Type:
Biological Skin Substitutes
Enzyme Preparation
Growth Factor
Global Wound Biologics market, by Application
Hospital
Drugstore
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Wound Biologics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Wound Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Wound Biologics Market Overview
1.1 Wound Biologics Product Overview
1.2 Wound Biologics Market Segment by Type
1.2.1 Biological Skin Substitutes
1.2.2 Enzyme Preparation
1.2.3 Growth Factor
1.3 Global Wound Biologics Market Size by Type
1.3.1 Global Wound Biologics Market Size Overview by Type (2018-2029)
1.3.2 Global Wound Biologics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Wound Biologics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Wound Biologics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Wound Biologics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Wound Biologics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Wound Biologics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Wound Biologics Sales Breakdown by Type (2018-2023)
2 Global Wound Biologics Market Competition by Company
2.1 Global Top Players by Wound Biologics Sales (2018-2023)
2.2 Global Top Players by Wound Biologics Revenue (2018-2023)
2.3 Global Top Players by Wound Biologics Price (2018-2023)
2.4 Global Top Manufacturers Wound Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Wound Biologics Market Competitive Situation and Trends
2.5.1 Wound Biologics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Wound Biologics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Wound Biologics as of 2022)
2.7 Date of Key Manufacturers Enter into Wound Biologics Market
2.8 Key Manufacturers Wound Biologics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Wound Biologics Status and Outlook by Region
3.1 Global Wound Biologics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Wound Biologics Historic Market Size by Region
3.2.1 Global Wound Biologics Sales in Volume by Region (2018-2023)
3.2.2 Global Wound Biologics Sales in Value by Region (2018-2023)
3.2.3 Global Wound Biologics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Wound Biologics Forecasted Market Size by Region
3.3.1 Global Wound Biologics Sales in Volume by Region (2024-2029)
3.3.2 Global Wound Biologics Sales in Value by Region (2024-2029)
3.3.3 Global Wound Biologics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Wound Biologics by Application
4.1 Wound Biologics Market Segment by Application
4.1.1 Hospital
4.1.2 Drugstore
4.1.3 Others
4.2 Global Wound Biologics Market Size by Application
4.2.1 Global Wound Biologics Market Size Overview by Application (2018-2029)
4.2.2 Global Wound Biologics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Wound Biologics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Wound Biologics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Wound Biologics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Wound Biologics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Wound Biologics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Wound Biologics Sales Breakdown by Application (2018-2023)
5 North America Wound Biologics by Country
5.1 North America Wound Biologics Historic Market Size by Country
5.1.1 North America Wound Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Wound Biologics Sales in Volume by Country (2018-2023)
5.1.3 North America Wound Biologics Sales in Value by Country (2018-2023)
5.2 North America Wound Biologics Forecasted Market Size by Country
5.2.1 North America Wound Biologics Sales in Volume by Country (2024-2029)
5.2.2 North America Wound Biologics Sales in Value by Country (2024-2029)
6 Europe Wound Biologics by Country
6.1 Europe Wound Biologics Historic Market Size by Country
6.1.1 Europe Wound Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Wound Biologics Sales in Volume by Country (2018-2023)
6.1.3 Europe Wound Biologics Sales in Value by Country (2018-2023)
6.2 Europe Wound Biologics Forecasted Market Size by Country
6.2.1 Europe Wound Biologics Sales in Volume by Country (2024-2029)
6.2.2 Europe Wound Biologics Sales in Value by Country (2024-2029)
7 Asia-Pacific Wound Biologics by Region
7.1 Asia-Pacific Wound Biologics Historic Market Size by Region
7.1.1 Asia-Pacific Wound Biologics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Wound Biologics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Wound Biologics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Wound Biologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Wound Biologics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Wound Biologics Sales in Value by Region (2024-2029)
8 Latin America Wound Biologics by Country
8.1 Latin America Wound Biologics Historic Market Size by Country
8.1.1 Latin America Wound Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Wound Biologics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Wound Biologics Sales in Value by Country (2018-2023)
8.2 Latin America Wound Biologics Forecasted Market Size by Country
8.2.1 Latin America Wound Biologics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Wound Biologics Sales in Value by Country (2024-2029)
9 Middle East and Africa Wound Biologics by Country
9.1 Middle East and Africa Wound Biologics Historic Market Size by Country
9.1.1 Middle East and Africa Wound Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Wound Biologics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Wound Biologics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Wound Biologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Wound Biologics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Wound Biologics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Avita Medical
10.1.1 Avita Medical Company Information
10.1.2 Avita Medical Introduction and Business Overview
10.1.3 Avita Medical Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Avita Medical Wound Biologics Products Offered
10.1.5 Avita Medical Recent Development
10.2 ConvaTec
10.2.1 ConvaTec Company Information
10.2.2 ConvaTec Introduction and Business Overview
10.2.3 ConvaTec Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ConvaTec Wound Biologics Products Offered
10.2.5 ConvaTec Recent Development
10.3 Acelity
10.3.1 Acelity Company Information
10.3.2 Acelity Introduction and Business Overview
10.3.3 Acelity Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Acelity Wound Biologics Products Offered
10.3.5 Acelity Recent Development
10.4 Cytori Therapeutic
10.4.1 Cytori Therapeutic Company Information
10.4.2 Cytori Therapeutic Introduction and Business Overview
10.4.3 Cytori Therapeutic Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cytori Therapeutic Wound Biologics Products Offered
10.4.5 Cytori Therapeutic Recent Development
10.5 MacroCure
10.5.1 MacroCure Company Information
10.5.2 MacroCure Introduction and Business Overview
10.5.3 MacroCure Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 MacroCure Wound Biologics Products Offered
10.5.5 MacroCure Recent Development
10.6 Nuo Therapeutics
10.6.1 Nuo Therapeutics Company Information
10.6.2 Nuo Therapeutics Introduction and Business Overview
10.6.3 Nuo Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nuo Therapeutics Wound Biologics Products Offered
10.6.5 Nuo Therapeutics Recent Development
10.7 Molyncke Health Care
10.7.1 Molyncke Health Care Company Information
10.7.2 Molyncke Health Care Introduction and Business Overview
10.7.3 Molyncke Health Care Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Molyncke Health Care Wound Biologics Products Offered
10.7.5 Molyncke Health Care Recent Development
10.8 Osiris Therapeutics
10.8.1 Osiris Therapeutics Company Information
10.8.2 Osiris Therapeutics Introduction and Business Overview
10.8.3 Osiris Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Osiris Therapeutics Wound Biologics Products Offered
10.8.5 Osiris Therapeutics Recent Development
10.9 Smith And Nephew
10.9.1 Smith And Nephew Company Information
10.9.2 Smith And Nephew Introduction and Business Overview
10.9.3 Smith And Nephew Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Smith And Nephew Wound Biologics Products Offered
10.9.5 Smith And Nephew Recent Development
10.10 Organogenesis
10.10.1 Organogenesis Company Information
10.10.2 Organogenesis Introduction and Business Overview
10.10.3 Organogenesis Wound Biologics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Organogenesis Wound Biologics Products Offered
10.10.5 Organogenesis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Wound Biologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Wound Biologics Industrial Chain Analysis
11.4 Wound Biologics Market Dynamics
11.4.1 Wound Biologics Industry Trends
11.4.2 Wound Biologics Market Drivers
11.4.3 Wound Biologics Market Challenges
11.4.4 Wound Biologics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Wound Biologics Distributors
12.3 Wound Biologics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
